-
Major Drivers of MS Therapy Costs in US: Profit and Competitors’ Prices, Pharma Execs Says
A study based on interviews with four executives in the MS field found therapy prices driven largely by others’ prices and company profit, not research. Read the full story here.
Do these findings surprise you? Why or why not?
Sorry, there were no replies found.
Log in to reply.